Glaucoma is the second most common irreversible cause of blindness worldwide. It is becoming increasingly important in the context of an aging world population. It possesses a considerable challenge to public health because blindness and visual impairment is costly and have a huge impact on life quality. Raised intraocular pressure (IOP) remains the only successful treatable factor to reduce th...

OBJECTIVE To study trends of glaucoma medication expenditure from 2001 to 2006 using a nationally representative sample of US adults. METHODS We analyzed glaucoma medication expenditure trends among participants of the 2001-2006 Medical Expenditure Panel Survey, a subsample of the National Health Interview Survey, which is a continuous multipurpose, multistage area probability survey of the U...

OBJECTIVES To evaluate intraocular pressure (IOP) and glaucoma control following phacoemulsification with posterior chamber intraocular lens implantation in patients who had chronic angle closure glaucoma (CACG) whose peripheral anterior synechiae (PAS) were less than 270 degrees. DESIGN Non-randomized consecutive cases series. PARTICIPANTS CACG cases at the glaucoma service, Ramathibodi Ho...

purpose: to evaluate the early and intermediate outcomes of ahmed glaucoma valve implantation in pediatric glaucoma at labbafinejad medical center. methods: this was a retrospective chart review of 101 eyes of 80 consecutive patients with pediatric glaucoma who underwent ahmed glaucoma valve implantation. success was defined as an intraocular pressure less than 21 mmhg with or without medicatio...

Glaucoma is an insidious disease. Its medical treatments are expensive, long term, require regular follow-up, can cause immediate side effects, and work by preventing, but not reversing, visual loss. Therefore, not surprisingly, adherence with glaucoma medications is a particular challenge. One of the most difficult to manage situations is the patient who states that he has good medication adhe...

purpose: to evaluate intermediate-term results of baerveldt tube implantation for treatment of refractory glaucoma in young patients. methods: we retrospectively studied 14 eyes of 11 consecutive patients aged<20 years with refractory glaucoma who underwent baerveldt tube implantation after 1 to 3 previous surgical procedures. the glaucoma was congenital in eight eyes and following congenital c...

BACKGROUND We studied the effect of argon laser trabeculoplasty (ALT) on medically controlled, pressure-stable glaucoma patients to verify whether it is possible to reduce ocular hypotensive medication after ALT while keeping intraocular pressure levels similar to those observed before the procedure. METHODS Seventy-one consecutive chronic glaucoma patients, all of whom were taking ocular hyp...